BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1588992)

  • 1. Synthetic surfactants in infants with respiratory distress syndrome.
    Perlman JM; Moya F
    N Engl J Med; 1992 Jun; 326(25):1703-4; author reply 1704-5. PubMed ID: 1588992
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic surfactant.
    Long W
    Semin Perinatol; 1993 Aug; 17(4):275-84. PubMed ID: 8140442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatments of respiratory distress syndrome in premature infants].
    Saliba E; Laugier J
    Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant and the neonatal lung.
    Gibson AT
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic surfactants in infants with respiratory distress syndrome.
    Egan EA
    N Engl J Med; 1992 Jun; 326(25):1704; author reply 1704-5. PubMed ID: 1588993
    [No Abstract]   [Full Text] [Related]  

  • 6. Surfactant for respiratory distress syndrome.
    Bierman SF
    N Engl J Med; 1989 Sep; 321(12):834. PubMed ID: 2671737
    [No Abstract]   [Full Text] [Related]  

  • 7. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?
    Chima RS; Zingarelli B
    Crit Care Med; 2007 Oct; 35(10):2442-3. PubMed ID: 17885382
    [No Abstract]   [Full Text] [Related]  

  • 8. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome.
    Hallman M; Merritt TA; Schneider H; Epstein BL; Mannino F; Edwards DK; Gluck L
    Pediatrics; 1983 Apr; 71(4):473-82. PubMed ID: 6340042
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the treatment of the respiratory distress syndrome in premature infants with tris(hydroxymethyl)-aminomethane (THAM) and wetting agents].
    Jarre W; Ketterle W; Reinwein H
    Helv Paediatr Acta; 1965 Apr; 20(1):27-39. PubMed ID: 5828973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Exogenous surfactant preparations].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Pneumonol Alergol Pol; 1998; 66(1-2):127-32. PubMed ID: 9658893
    [No Abstract]   [Full Text] [Related]  

  • 12. RDS and surfactant replacement: the double-edged sword.
    Etherington H; Lawrence J; Davis D
    Can Nurse; 1993 Jan; 89(1):14-7. PubMed ID: 8425163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Factors affecting clinical response to surfactant therapy in neonates with severe respiratory distress syndrome].
    Fujiwara T; Chida S; Konishi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):29-34. PubMed ID: 2041254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New avenues in surfactant research.
    Robertson B
    Z Geburtshilfe Neonatol; 2001; 205(3):77-8. PubMed ID: 11474993
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine output in infants with respiratory distress syndrome treated with surfactant.
    Hamdan AH; Shaw NJ
    Clin Pediatr (Phila); 2000 Jul; 39(7):421-5. PubMed ID: 10914308
    [No Abstract]   [Full Text] [Related]  

  • 16. Artificial surfactant to prevent and treat neonatal respiratory distress syndrome.
    Enhorning G
    Pediatrics; 1980 Nov; 66(5):799-800. PubMed ID: 7432889
    [No Abstract]   [Full Text] [Related]  

  • 17. Fifth time's the charm for infant respiratory distress drug.
    Katsnelson A
    Nat Biotechnol; 2012 May; 30(5):380. PubMed ID: 22565949
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membrane syndrome (respiratory distress syndrome) in newborn infants. Pathogenesis and therapy with special regard to alveolar surface active agent].
    Keuth U
    Fortschr Med; 1973 Jun; 91(16):693-7. PubMed ID: 4740218
    [No Abstract]   [Full Text] [Related]  

  • 20. Does surfactant therapy prolong dying? Age at in-hospital death of extremely premature babies.
    Coulter DM; Jung AL
    J Perinatol; 1996; 16(3 Pt 1):166-70; quiz 171-2. PubMed ID: 8817423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.